中财网 中财网股票行情
恒瑞医药(600276)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)2018930.381360073.41599753.392281978.471701363.22
营业收入(万元)2018930.381360073.41599753.392281978.471701363.22
营业总成本(万元)1508997.92975600.04442578.231830411.461327456.80
营业成本(万元)283318.27187330.3794284.94352524.78265755.41
净利润(万元)460807.66343097.53136278.73431853.01348469.65
归属于母公司的净利润(万元)461957.59343174.81136892.92430243.59347377.92
营业利润(万元)534529.05398477.61163600.88490990.49394132.95
利润总额(万元)508674.02375160.01150251.08466710.97381237.69
少数股东损益(万元)-324.57-361.57-144.06-2461.52-2274.93
基本每股收益(元)0.73(元)0.54(元)0.21(元)0.68(元)0.55(元)
稀释每股收益(元)0.73(元)0.54(元)0.21(元)0.68(元)0.55(元)
非经常性损益(万元)-----7155.1016117.3211358.37
扣除非经常性损益后净利润(万元)461631.48349005.15144048.03414126.28336019.55
总资产(万元)4833809.944818136.004634000.144378450.664287139.07
总负债(万元)400658.07499422.39390064.60275142.02266480.46
归属于母公司股东权益合计(万元)4376790.884262224.284187350.484046579.543963690.06
股东权益合计(万元)4433151.874318713.624243935.534103308.644020658.61
实收资本(股本)(万元)637900.23637900.23637900.23637900.23637900.23
资本公积(万元)322235.23316704.24311256.51305763.90317114.43
未分配利润(万元)3214857.793096075.013017169.962880277.032797436.11
经营活动产生的现金流量净额(万元)458544.60303275.48125459.89764366.51430887.12
经营活动现金流入小计(万元)2054679.711383831.96613605.142545507.241645626.99
经营活动现金流出小计(万元)1596135.111080556.47488145.251781140.731214739.88
投资活动产生的现金流量净额(万元)-187344.65-152359.24-75039.02122231.51123758.65
投资活动现金流入小计(万元)25122.104108.131063.16272319.24261022.71
投资活动现金流出小计(万元)212466.75156467.3776102.19150087.73137264.07
筹资活动产生的现金流量净额(万元)-150652.41-13856.75-1813.46-314442.63-308994.30
筹资活动现金流入小计(万元)79990.9479990.94--2110.002110.00
筹资活动现金流出小计(万元)230643.3493847.691813.46316552.63311104.30
期末现金及现金等价物余额(万元)2145578.022163628.072073939.022027152.431701364.77
最后修改日期2024-10-242024-08-212024-04-182024-04-182023-10-26
↑返回页顶↑

转至恒瑞医药（600276）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。